Role of hypofractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.
İrem KoçSezin Yüce SarıGözde YazıcıYasemin KapucuHayyam KıratlıFaruk ZorluPublished in: Neuro-oncology practice (2023)
Hypofractionated stereotactic radiotherapy is a safe and satisfactory treatment option for primary ONSM without severe toxicity. It may be advisable to commence treatment before an established visual deficit of 20/400 or worse occurs, to make the most of the functional benefit.